Travere Therapeutics, Inc.TVTXNASDAQ
LOADING
|||
Gross Profit Over Time
Trending higher, above historical average, modest growth trend.
Left:
||||
Revenue minus cost of goods sold
Latest
$225.43M
↑ 51% above average
Average (9y)
$149.14M
Historical baseline
Range
High:$225.43M
Low:$97.71M
CAGR
+9.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $225.43M | +68.5% |
| 2023 | $133.79M | +27.4% |
| 2022 | $105.04M | -17.9% |
| 2021 | $128.02M | -33.4% |
| 2020 | $192.19M | +13.0% |
| 2019 | $170.10M | +7.2% |
| 2018 | $158.72M | +4.9% |
| 2017 | $151.33M | +17.3% |
| 2016 | $129.04M | +32.1% |
| 2015 | $97.71M | - |